The Look AHEAD study: a description of the lifestyle intervention and the evidence supporting it
- PMID: 16855180
- PMCID: PMC2613279
- DOI: 10.1038/oby.2006.84
The Look AHEAD study: a description of the lifestyle intervention and the evidence supporting it
Erratum in
- Obesity (Silver Spring). 2007 May;15(5):1339. Wadden, Thomas A [added]; West, Delia Smith [added]; Delahanty, Linda [added]; Jakicic, John [added]; Rejeski, Jack [added]; Williamson, Don [added]; Berkowitz, Robert I [added]; Kelley, David E [added]; Tomchee, Christine [added]; Hill, James O [added]; K
Abstract
The Look AHEAD (Action for Health in Diabetes) study is a multicenter, randomized controlled trial designed to determine whether intentional weight loss reduces cardiovascular morbidity and mortality in overweight individuals with type 2 diabetes. The study began in 2001 and is scheduled to conclude in 2012. A total of 5145 participants have been randomly assigned to a lifestyle intervention or to an enhanced usual care condition (i.e., diabetes support and education). This article describes the lifestyle intervention and the empirical evidence to support it. The two principal intervention goals are to induce a mean loss >or = 7% of initial weight and to increase participants' moderately intense physical activity to > or =175 min/wk. For the first 6 months, participants attend one individual and three group sessions per month and are encouraged to replace two meals and one snack a day with liquid shakes and meal bars. From months 7 to 12, they attend one individual and two group meetings per month and continue to replace one meal per day (which is recommended for the study's duration). Starting at month 7, more intensive behavioral interventions and weight loss medication are available from a toolbox, designed to help participants with limited weight loss. In Years 2 to 4, treatment is provided mainly on an individual basis and includes at least one on-site visit per month and a second contact by telephone, mail, or e-mail. After Year 4, participants are offered monthly individual visits. The intervention is delivered by a multidisciplinary team that includes medical staff who monitor participants at risk of hypoglycemic episodes.
Figures
Similar articles
-
Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial.Lancet Diabetes Endocrinol. 2016 Nov;4(11):913-921. doi: 10.1016/S2213-8587(16)30162-0. Epub 2016 Aug 30. Lancet Diabetes Endocrinol. 2016. PMID: 27595918 Free PMC article. Clinical Trial.
-
The results of Look AHEAD do not row against the implementation of lifestyle changes in patients with type 2 diabetes.Nutr Metab Cardiovasc Dis. 2014 Jan;24(1):4-9. doi: 10.1016/j.numecd.2013.12.001. Epub 2013 Dec 20. Nutr Metab Cardiovasc Dis. 2014. PMID: 24388434
-
Effect of a lifestyle intervention on change in cardiorespiratory fitness in adults with type 2 diabetes: results from the Look AHEAD Study.Int J Obes (Lond). 2009 Mar;33(3):305-16. doi: 10.1038/ijo.2008.280. Epub 2009 Jan 20. Int J Obes (Lond). 2009. PMID: 19153582 Free PMC article. Clinical Trial.
-
Implications of the diabetes prevention program and Look AHEAD clinical trials for lifestyle interventions.J Am Diet Assoc. 2008 Apr;108(4 Suppl 1):S66-72. doi: 10.1016/j.jada.2008.01.026. J Am Diet Assoc. 2008. PMID: 18358260 Free PMC article. Review.
-
Is weight loss beneficial for reduction of morbidity and mortality? What is the controversy about?Diabetes Care. 2008 Feb;31 Suppl 2:S278-83. doi: 10.2337/dc08-s268. Diabetes Care. 2008. PMID: 18227497 Review.
Cited by
-
Within and post-trial effects of an intensive lifestyle intervention on kidney disease in adults with overweight or obesity and type 2 diabetes mellitus: a secondary analysis of the Look AHEAD clinical trial.BMJ Open Diabetes Res Care. 2024 May 30;12(3):e004079. doi: 10.1136/bmjdrc-2024-004079. BMJ Open Diabetes Res Care. 2024. PMID: 38816203 Free PMC article. Clinical Trial.
-
Lessons Learned from Telemedicine in Adolescent Obesity: Results of a Pilot Study.Children (Basel). 2024 May 16;11(5):599. doi: 10.3390/children11050599. Children (Basel). 2024. PMID: 38790594 Free PMC article.
-
Sex Specific Associations of Sex hormone With Brain Volumes and Cerebral Blood Flow: A Cross Sectional Observational Study Within the Look AHEAD Type 2 Diabetes Cohort.Res Sq [Preprint]. 2024 Apr 29:rs.3.rs-4254188. doi: 10.21203/rs.3.rs-4254188/v1. Res Sq. 2024. PMID: 38746210 Free PMC article. Preprint.
-
The 10-Year Effects of Intensive Lifestyle Intervention on Kidney Outcomes.Kidney Med. 2024 Mar 22;6(5):100814. doi: 10.1016/j.xkme.2024.100814. eCollection 2024 May. Kidney Med. 2024. PMID: 38689836 Free PMC article.
-
Obesity and cardiovascular health.Eur J Prev Cardiol. 2024 Jun 3;31(8):1026-1035. doi: 10.1093/eurjpc/zwae025. Eur J Prev Cardiol. 2024. PMID: 38243826 Free PMC article. Review.
References
-
- The Look AHEAD Research Group Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Controlled Clinical Trials. 2003;24:610–628. - PubMed
-
- Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, Liu PA, Jiang XG, Jiang YY, Wang JP, Zheng H, Zhang H, Bennett PH, Howard BV. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Quing IGT and Diabetes Study. Diabetes Care. 1997;20:537–544. - PubMed
-
- Tuomilehto JLJ, Eriksson JG, Valle TT, Hamalainin H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–1392. - PubMed
-
- Guare JC, Wing RR, Grant A. Comparison of obese NIDDM and nondiabetic women: short- and long-term weight loss. Obes Res. 1995;3:329–335. - PubMed
Publication types
MeSH terms
Grants and funding
- DK57078/DK/NIDDK NIH HHS/United States
- M01RR00211-40/RR/NCRR NIH HHS/United States
- U01 DK057136-02/DK/NIDDK NIH HHS/United States
- U01 DK057151/DK/NIDDK NIH HHS/United States
- DK57151/DK/NIDDK NIH HHS/United States
- U01 DK057136-05/DK/NIDDK NIH HHS/United States
- P30 DK048520/DK/NIDDK NIH HHS/United States
- U01 DK057135/DK/NIDDK NIH HHS/United States
- P30 DK046204/DK/NIDDK NIH HHS/United States
- DK57171/DK/NIDDK NIH HHS/United States
- M01 RR002719/RR/NCRR NIH HHS/United States
- U01 DK057136-10/DK/NIDDK NIH HHS/United States
- DK57131/DK/NIDDK NIH HHS/United States
- M01 RR000056/RR/NCRR NIH HHS/United States
- U01 DK057219/DK/NIDDK NIH HHS/United States
- U01 DK057154/DK/NIDDK NIH HHS/United States
- DK57149/DK/NIDDK NIH HHS/United States
- U01 DK056992/DK/NIDDK NIH HHS/United States
- U01 DK057136-05S1/DK/NIDDK NIH HHS/United States
- M01 RR00051/RR/NCRR NIH HHS/United States
- U01 DK057171/DK/NIDDK NIH HHS/United States
- U01 DK057136-08/DK/NIDDK NIH HHS/United States
- U01 DK057136-01/DK/NIDDK NIH HHS/United States
- DK57182/DK/NIDDK NIH HHS/United States
- DK57002/DK/NIDDK NIH HHS/United States
- M01 RR000056 44/RR/NCRR NIH HHS/United States
- U01 DK057182/DK/NIDDK NIH HHS/United States
- M01-RR-02719/RR/NCRR NIH HHS/United States
- U01 DK057136-07/DK/NIDDK NIH HHS/United States
- U01 DK057136/DK/NIDDK NIH HHS/United States
- U01 DK057002/DK/NIDDK NIH HHS/United States
- U01 DK057136-09S1/DK/NIDDK NIH HHS/United States
- DK57178/DK/NIDDK NIH HHS/United States
- M01 RR000211/RR/NCRR NIH HHS/United States
- P30 DK48520/DK/NIDDK NIH HHS/United States
- U01 DK057177/DK/NIDDK NIH HHS/United States
- U01 DK057136-04/DK/NIDDK NIH HHS/United States
- U01 DK057078/DK/NIDDK NIH HHS/United States
- U01 DK057136-06/DK/NIDDK NIH HHS/United States
- U01 DK057136-04S1/DK/NIDDK NIH HHS/United States
- DK57008/DK/NIDDK NIH HHS/United States
- U01 DK057131/DK/NIDDK NIH HHS/United States
- M01 RR000051/RR/NCRR NIH HHS/United States
- DK57136/DK/NIDDK NIH HHS/United States
- DK57154/DK/NIDDK NIH HHS/United States
- U01 DK057136-03S1/DK/NIDDK NIH HHS/United States
- DK57219/DK/NIDDK NIH HHS/United States
- DK57177/DK/NIDDK NIH HHS/United States
- U01 DK056990/DK/NIDDK NIH HHS/United States
- U01 DK057178/DK/NIDDK NIH HHS/United States
- U01 DK057136-03/DK/NIDDK NIH HHS/United States
- U01 DK057008/DK/NIDDK NIH HHS/United States
- DK56990/DK/NIDDK NIH HHS/United States
- DK 046204/DK/NIDDK NIH HHS/United States
- U01 DK057149/DK/NIDDK NIH HHS/United States
- U01 DK057136-04S2/DK/NIDDK NIH HHS/United States
- U01 DK057136-08S1/DK/NIDDK NIH HHS/United States
- DK57135/DK/NIDDK NIH HHS/United States
- U01 DK057136-09/DK/NIDDK NIH HHS/United States
- DK56992/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical